TY - JOUR AU - Bonner, N. AU - Abetz-Webb, L. AU - Renault, L. AU - Caballero, T. AU - Longhurst, H. AU - Maurer, M. PY - 2015 DA - 2015// TI - Development and content validity testing of a patient-reported outcomes questionnaire for the assessment of hereditary angioedema in observational studies JO - Health Qual Life Outcomes VL - 13 UR - https://doi.org/10.1186/s12955-015-0292-7 DO - 10.1186/s12955-015-0292-7 ID - Bonner2015 ER - TY - JOUR AU - Bogart, K. R. AU - Irvin, V. L. PY - 2017 DA - 2017// TI - Health-related quality of life among adults with diverse rare disorders JO - Orphanet J Rare Dis. VL - 12 UR - https://doi.org/10.1186/s13023-017-0730-1 DO - 10.1186/s13023-017-0730-1 ID - Bogart2017 ER - TY - BOOK PY - 2010 DA - 2010// TI - Health-Related Quality of Life and Well-Being ID - ref3 ER - TY - JOUR AU - Robbins, D. A. AU - Curro, F. A. AU - Fox, C. H. PY - 2013 DA - 2013// TI - Defining patient-centricity: opportunities, challenges, and implications for clinical care and research JO - Ther Innov Regul Sci VL - 47 UR - https://doi.org/10.1177/2168479013484159 DO - 10.1177/2168479013484159 ID - Robbins2013 ER - TY - STD TI - FDA. Guidance for Industry Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims Clinical/Medical Guidance for Industry Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. Health Qual Life Outcomes. 2006;4:79. https://doi.org/10.1186/1477-7525-4-79. ID - ref5 ER - TY - JOUR AU - Basch, E. t. h. a. n. AU - Bennett, A. n. t. o. n. i. a. V. PY - 2014 DA - 2014// TI - Patient-Reported Outcomes in Clinical Trials of Rare Diseases JO - Journal of General Internal Medicine VL - 29 UR - https://doi.org/10.1007/s11606-014-2892-z DO - 10.1007/s11606-014-2892-z ID - Basch2014 ER - TY - JOUR AU - Bevans, M. AU - Ross, A. AU - Cella, D. PY - 2014 DA - 2014// TI - Patient-reported outcomes measurement information system (PROMIS): efficient, standardized tools to measure self-reported health and quality of life JO - Nurs Outlook VL - 62 UR - https://doi.org/10.1016/j.outlook.2014.05.009 DO - 10.1016/j.outlook.2014.05.009 ID - Bevans2014 ER - TY - JOUR AU - Bresnahan, B. W. AU - Rundell, S. D. PY - 2014 DA - 2014// TI - Including patient-reported outcomes and patient-reported resource-use questionnaires in studies JO - Acad Radiol VL - 21 UR - https://doi.org/10.1016/j.acra.2014.05.008 DO - 10.1016/j.acra.2014.05.008 ID - Bresnahan2014 ER - TY - JOUR AU - Kyte, D. G. AU - Calvert, M. AU - van der Wees, P. J. AU - ten Hove, R. AU - Tolan, S. AU - Hill, J. C. PY - 2015 DA - 2015// TI - An introduction to patient-reported outcome measures (PROMs) in physiotherapy JO - Physiotherapy VL - 101 UR - https://doi.org/10.1016/j.physio.2014.11.003 DO - 10.1016/j.physio.2014.11.003 ID - Kyte2015 ER - TY - JOUR AU - Slade, A. AU - Isa, F. AU - Kyte, D. AU - Pankhurst, T. AU - Kerecuk, L. AU - Ferguson, J. PY - 2018 DA - 2018// TI - Patient reported outcome measures in rare diseases: a narrative review JO - Orphanet J Rare Dis. VL - 13 UR - https://doi.org/10.1186/s13023-018-0810-x DO - 10.1186/s13023-018-0810-x ID - Slade2018 ER - TY - BOOK PY - 2005 DA - 2005// TI - Reflection paper on the regulatory guidance for the use of health-related quality of life (HRQL) measures in the evaluation of medicinal products ID - ref11 ER - TY - JOUR AU - Dinan, M. AU - Compton, K. AU - Dhillon, J. PY - 2011 DA - 2011// TI - Use of patient-reported outcomes in randomized, double-blind, placebo-controlled clinical trials JO - Med Care VL - 49 UR - https://doi.org/10.1097/MLR.0b013e3182064aa2 DO - 10.1097/MLR.0b013e3182064aa2 ID - Dinan2011 ER - TY - JOUR AU - Brundage, M. AU - Bass, B. AU - Davidson, J. AU - Queenan, J. AU - Bezjak, A. AU - Ringash, J. PY - 2011 DA - 2011// TI - Patterns of reporting health-related quality of life outcomes in randomized clinical trials: implications for clinicians and quality of life researchers JO - Qual Life Res VL - 20 UR - https://doi.org/10.1007/s11136-010-9793-3 DO - 10.1007/s11136-010-9793-3 ID - Brundage2011 ER - TY - JOUR AU - Wiklund, I. PY - 2004 DA - 2004// TI - Assessment of patient-reported outcomes in clinical trials: the example of health-related quality of life JO - Fundam Clin Pharmacol VL - 18 UR - https://doi.org/10.1111/j.1472-8206.2004.00234.x DO - 10.1111/j.1472-8206.2004.00234.x ID - Wiklund2004 ER - TY - JOUR AU - Zeltner, N. A. AU - Huemer, M. AU - Baumgartner, M. R. AU - Landolt, M. A. PY - 2014 DA - 2014// TI - Quality of life, psychological adjustment, and adaptive functioning of patients with intoxication-type inborn errors of metabolism - a systematic review JO - Orphanet J Rare Dis. VL - 9 UR - https://doi.org/10.1186/s13023-014-0159-8 DO - 10.1186/s13023-014-0159-8 ID - Zeltner2014 ER - TY - JOUR AU - Ridgeway, J. L. AU - Beebe, T. J. AU - Chute, C. G. AU - Eton, D. T. AU - Hart, L. A. AU - Frost, M. H. PY - 2013 DA - 2013// TI - A brief patient-reported outcomes quality of life (PROQOL) instrument to improve patient care JO - PLoS Med VL - 10 UR - https://doi.org/10.1371/journal.pmed.1001548 DO - 10.1371/journal.pmed.1001548 ID - Ridgeway2013 ER - TY - JOUR AU - Nelson, E. C. AU - Eftimovska, E. AU - Lind, C. AU - Hager, A. AU - Wasson, J. H. AU - Lindblad, S. PY - 2015 DA - 2015// TI - Patient reported outcome measures in practice JO - BMJ VL - 350 UR - https://doi.org/10.1136/bmj.g7818 DO - 10.1136/bmj.g7818 ID - Nelson2015 ER - TY - JOUR AU - Khangura, S. D. AU - Karaceper, M. D. AU - Trakadis, Y. AU - Mitchell, J. J. AU - Chakraborty, P. AU - Tingley, K. PY - 2015 DA - 2015// TI - Scoping review of patient- and family-oriented outcomes and measures for chronic pediatric disease JO - BMC Pediatr VL - 15 UR - https://doi.org/10.1186/s12887-015-0323-x DO - 10.1186/s12887-015-0323-x ID - Khangura2015 ER - TY - JOUR AU - Johnston, B. C. AU - Miller, P. A. AU - Agarwal, A. AU - Mulla, S. AU - Khokhar, R. AU - De Oliveira, K. PY - 2016 DA - 2016// TI - Limited responsiveness related to the minimal important difference of patient-reported outcomes in rare diseases JO - J Clin Epidemiol VL - 79 UR - https://doi.org/10.1016/j.jclinepi.2016.06.010 DO - 10.1016/j.jclinepi.2016.06.010 ID - Johnston2016 ER - TY - JOUR AU - Verstovsek, S. AU - Mesa, R. A. AU - Gotlib, J. AU - Levy, R. S. AU - Gupta, V. AU - DiPersio, J. F. PY - 2012 DA - 2012// TI - A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis JO - N Engl J Med VL - 366 UR - https://doi.org/10.1056/NEJMoa1110557 DO - 10.1056/NEJMoa1110557 ID - Verstovsek2012 ER - TY - JOUR AU - Mak, C. M. AU - Lee, H. -. C. H. AU - Chan, A. Y. -. W. AU - Lam, C. -. W. PY - 2013 DA - 2013// TI - Inborn errors of metabolism and expanded newborn screening: review and update JO - Crit Rev Clin Lab Sci VL - 50 UR - https://doi.org/10.3109/10408363.2013.847896 DO - 10.3109/10408363.2013.847896 ID - Mak2013 ER - TY - JOUR AU - Bennett, M. J. PY - 2014 DA - 2014// TI - Newborn screening for metabolic diseases: saving children’s lives and improving outcomes JO - Clin Biochem VL - 47 UR - https://doi.org/10.1016/j.clinbiochem.2014.05.010 DO - 10.1016/j.clinbiochem.2014.05.010 ID - Bennett2014 ER - TY - CHAP AU - Matern, D. i. e. t. r. i. c. h. AU - Rinaldo, P. i. e. r. o. PY - 2016 DA - 2016// TI - Newborn Screening for Inherited Metabolic Disease BT - Inherited Metabolic Diseases PB - Springer Berlin Heidelberg CY - Berlin, Heidelberg ID - Matern2016 ER - TY - JOUR AU - Eminoglu, T. F. AU - Soysal, S. A. AU - Tumer, L. AU - Okur, I. AU - Hasanoglu, A. PY - 2013 DA - 2013// TI - Quality of life in children treated with restrictive diet for inherited metabolic disease JO - Pediatr Int VL - 55 UR - https://doi.org/10.1111/ped.12089 DO - 10.1111/ped.12089 ID - Eminoglu2013 ER - TY - JOUR AU - Huang, M. E. AU - Wartella, J. E. AU - Kreutzer, J. S. PY - 2001 DA - 2001// TI - Functional outcomes and quality of life in patients with brain tumors: a preliminary report JO - Arch Phys Med Rehabil VL - 82 UR - https://doi.org/10.1053/apmr.2001.26613 DO - 10.1053/apmr.2001.26613 ID - Huang2001 ER - TY - JOUR AU - Picavet, E. AU - Cassiman, D. AU - Hollak, C. E. AU - Maertens, J. A. AU - Simoens, S. PY - 2013 DA - 2013// TI - Clinical evidence for orphan medicinal products-a cause for concern? JO - Orphanet J Rare Dis VL - 8 UR - https://doi.org/10.1186/1750-1172-8-164 DO - 10.1186/1750-1172-8-164 ID - Picavet2013 ER - TY - JOUR AU - Arksey, H. AU - O’Malley, L. PY - 2005 DA - 2005// TI - Scoping studies: towards a methodological framework JO - Int J Soc Res Methodol VL - 8 UR - https://doi.org/10.1080/1364557032000119616 DO - 10.1080/1364557032000119616 ID - Arksey2005 ER - TY - JOUR AU - Picot, J. AU - Copley, V. AU - Colquitt, J. L. AU - Kalita, N. AU - Hartwell, D. AU - Bryant, J. PY - 2015 DA - 2015// TI - The INTRABEAM® photon radiotherapy system for the adjuvant treatment of early breast cancer: a systematic review and economic evaluation JO - Health Technol Assess (Rockv) VL - 19 UR - https://doi.org/10.3310/hta19690 DO - 10.3310/hta19690 ID - Picot2015 ER - TY - JOUR AU - Mathiowetz, N. A. AU - Groves, R. M. PY - 1985 DA - 1985// TI - The effects of respondent rules on health survey reports JO - Am J Public Health VL - 75 UR - https://doi.org/10.2105/AJPH.75.6.639 DO - 10.2105/AJPH.75.6.639 ID - Mathiowetz1985 ER - TY - JOUR AU - Landolt, M. A. AU - Nuoffer, J. -. M. AU - Steinmann, B. AU - Superti-Furga, A. PY - 2002 DA - 2002// TI - Quality of life and psychologic adjustment in children and adolescents with early treated phenylketonuria can be normal JO - J Pediatr VL - 140 UR - https://doi.org/10.1067/mpd.2002.123663 DO - 10.1067/mpd.2002.123663 ID - Landolt2002 ER - TY - JOUR AU - Cialone, J. AU - Adams, H. AU - Augustine, E. F. AU - Marshall, F. J. AU - Kwon, J. M. AU - Newhouse, N. PY - 2012 DA - 2012// TI - Females experience a more severe disease course in batten disease JO - J Inherit Metab Dis VL - 35 UR - https://doi.org/10.1007/s10545-011-9421-6 DO - 10.1007/s10545-011-9421-6 ID - Cialone2012 ER - TY - JOUR AU - Ceravolo, F. AU - Mascaro, I. AU - Sestito, S. AU - Pascale, E. AU - Lauricella, A. AU - Dizione, E. PY - 2013 DA - 2013// TI - Home treatment in paediatric patients with hunter syndrome: the first Italian experience JO - Ital J Pediatr VL - 39 UR - https://doi.org/10.1186/1824-7288-39-53 DO - 10.1186/1824-7288-39-53 ID - Ceravolo2013 ER - TY - JOUR AU - Eggink, H. AU - Kuiper, A. AU - Peall, K. J. AU - Contarino, M. F. AU - Bosch, A. M. AU - Post, B. PY - 2014 DA - 2014// TI - Rare inborn errors of metabolism with movement disorders: a case study to evaluate the impact upon quality of life and adaptive functioning JO - Orphanet J Rare Dis. VL - 9 UR - https://doi.org/10.1186/s13023-014-0177-6 DO - 10.1186/s13023-014-0177-6 ID - Eggink2014 ER - TY - JOUR AU - Splinter, K. AU - Niemi, A. -. K. AU - Cox, R. AU - Platt, J. AU - Shah, M. AU - Enns, G. M. PY - 2016 DA - 2016// TI - Impaired health-related quality of life in children and families affected by Methylmalonic Acidemia JO - J Genet Couns VL - 25 UR - https://doi.org/10.1007/s10897-015-9921-x DO - 10.1007/s10897-015-9921-x ID - Splinter2016 ER - TY - JOUR AU - Brands, M. M. G. AU - Gungor, D. AU - van den Hout, J. M. P. AU - Karstens, F. P. J. AU - Oussoren, E. AU - Plug, I. PY - 2015 DA - 2015// TI - Pain: a prevalent feature in patients with mucopolysaccharidosis. Results of a cross-sectional national survey JO - J Inherit Metab Dis VL - 38 UR - https://doi.org/10.1007/s10545-014-9737-0 DO - 10.1007/s10545-014-9737-0 ID - Brands2015 ER - TY - CHAP AU - Kunin-Batson, A. S. AU - Shapiro, E. G. AU - Rudser, K. D. AU - Lavery, C. A. AU - Bjoraker, K. J. AU - Jones, S. A. AU - Wynn, R. F. AU - Vellodi, A. AU - Tolar, J. AU - Orchard, P. J. AU - Wraith, J. E. PY - 2015 DA - 2015// TI - Long-Term Cognitive and Functional Outcomes in Children with Mucopolysaccharidosis (MPS)-IH (Hurler Syndrome) Treated with Hematopoietic Cell Transplantation BT - JIMD Reports PB - Springer Berlin Heidelberg CY - Berlin, Heidelberg ID - Kunin-Batson2015 ER - TY - JOUR AU - Shapiro, E. G. AU - Rudser, K. AU - Ahmed, A. AU - Steiner, R. D. AU - Delaney, K. A. AU - Yund, B. PY - 2016 DA - 2016// TI - A longitudinal study of emotional adjustment, quality of life and adaptive function in attenuated MPS II JO - Mol Genet Metab Reports VL - 7 UR - https://doi.org/10.1016/j.ymgmr.2016.03.005 DO - 10.1016/j.ymgmr.2016.03.005 ID - Shapiro2016 ER - TY - JOUR AU - Vockley, J. AU - Burton, B. AU - Berry, G. T. AU - Longo, N. AU - Phillips, J. AU - Sanchez-Valle, A. PY - 2017 DA - 2017// TI - UX007 for the treatment of long chain-fatty acid oxidation disorders: safety and efficacy in children and adults following 24weeks of treatment JO - Mol Genet Metab VL - 120 UR - https://doi.org/10.1016/j.ymgme.2017.02.005 DO - 10.1016/j.ymgme.2017.02.005 ID - Vockley2017 ER - TY - JOUR AU - Storch, E. AU - Keeley, M. AU - Merlo, L. AU - Jacob, M. AU - Correia, C. AU - Weinstein, D. PY - 2008 DA - 2008// TI - Psychosocial functioning in youth with glycogen storage disease type I JO - J Pediatr Psychol VL - 33 UR - https://doi.org/10.1093/jpepsy/jsn017 DO - 10.1093/jpepsy/jsn017 ID - Storch2008 ER - TY - JOUR AU - Goker-Alpan, O. AU - Longo, N. AU - McDonald, M. AU - Shankar, S. P. AU - Schiffmann, R. AU - Chang, P. PY - 2016 DA - 2016// TI - An open-label clinical trial of agalsidase alfa enzyme replacement therapy in children with Fabry disease who are naive to enzyme replacement therapy JO - Drug Des Devel Ther VL - 10 UR - https://doi.org/10.2147/DDDT.S102761 DO - 10.2147/DDDT.S102761 ID - Goker-Alpan2016 ER - TY - JOUR AU - Fabre, A. AU - Baumstarck, K. AU - Cano, A. AU - Loundou, A. AU - Berbis, J. AU - Chabrol, B. PY - 2013 DA - 2013// TI - Assessment of quality of life of the children and parents affected by inborn errors of metabolism with restricted diet: preliminary results of a cross-sectional study JO - Health Qual Life Outcomes VL - 11 UR - https://doi.org/10.1186/1477-7525-11-158 DO - 10.1186/1477-7525-11-158 ID - Fabre2013 ER - TY - JOUR AU - Raluy-Callado, M. AU - Chen, W. -. H. AU - Whiteman, D. A. H. AU - Fang, J. AU - Wiklund, I. PY - 2013 DA - 2013// TI - The impact of hunter syndrome (mucopolysaccharidosis type II) on health-related quality of life JO - Orphanet J Rare Dis. VL - 8 UR - https://doi.org/10.1186/1750-1172-8-101 DO - 10.1186/1750-1172-8-101 ID - Raluy-Callado2013 ER - TY - JOUR AU - Cazzorla, C. AU - Cegolon, L. AU - Burlina, A. P. AU - Celato, A. AU - Massa, P. AU - Giordano, L. PY - 2014 DA - 2014// TI - Quality of life (QoL) assessment in a cohort of patients with phenylketonuria JO - BMC Public Health VL - 14 UR - https://doi.org/10.1186/1471-2458-14-1243 DO - 10.1186/1471-2458-14-1243 ID - Cazzorla2014 ER - TY - JOUR AU - Feldmann, R. AU - Wolfgart, E. AU - Weglage, J. AU - Rutsch, F. PY - 2017 DA - 2017// TI - Sapropterin treatment does not enhance the health-related quality of life of patients with phenylketonuria and their parents JO - Acta Paediatr VL - 106 UR - https://doi.org/10.1111/apa.13799 DO - 10.1111/apa.13799 ID - Feldmann2017 ER - TY - JOUR AU - Thimm, E. AU - Schmidt, L. E. AU - Heldt, K. AU - Spiekerkoetter, U. PY - 2013 DA - 2013// TI - Health-related quality of life in children and adolescents with phenylketonuria: unimpaired HRQoL in patients but feared school failure in parents JO - J Inherit Metab Dis VL - 36 UR - https://doi.org/10.1007/s10545-012-9566-y DO - 10.1007/s10545-012-9566-y ID - Thimm2013 ER - TY - JOUR AU - Demirdas, S. AU - Maurice-Stam, H. AU - Boelen, C. C. A. AU - Hofstede, F. C. AU - Janssen, M. C. H. AU - Langendonk, J. G. PY - 2013 DA - 2013// TI - Evaluation of quality of life in PKU before and after introducing tetrahydrobiopterin (BH4); a prospective multi-center cohort study JO - Mol Genet Metab VL - 110 UR - https://doi.org/10.1016/j.ymgme.2013.09.015 DO - 10.1016/j.ymgme.2013.09.015 ID - Demirdas2013 ER - TY - JOUR AU - McGovern, M. M. AU - Wasserstein, M. P. AU - Giugliani, R. AU - Bembi, B. AU - Vanier, M. T. AU - Mengel, E. PY - 2008 DA - 2008// TI - A prospective, cross-sectional survey study of the natural history of Niemann-pick disease type B JO - Pediatrics VL - 122 UR - https://doi.org/10.1542/peds.2007-3016 DO - 10.1542/peds.2007-3016 ID - McGovern2008 ER - TY - JOUR AU - Packman, W. AU - Henderson, S. L. AU - Mehta, I. AU - Ronen, R. AU - Danner, D. AU - Chesterman, B. PY - 2007 DA - 2007// TI - Psychosocial issues in families affected by maple syrup urine disease JO - J Genet Couns VL - 16 UR - https://doi.org/10.1007/s10897-007-9114-3 DO - 10.1007/s10897-007-9114-3 ID - Packman2007 ER - TY - JOUR AU - Brands, M. M. M. G. AU - Oussoren, E. AU - Ruijter, G. J. G. AU - Vollebregt, A. A. M. AU - van den Hout, H. M. P. AU - Joosten, K. F. M. PY - 2013 DA - 2013// TI - Up to five years experience with 11 mucopolysaccharidosis type VI patients JO - Mol Genet Metab VL - 109 UR - https://doi.org/10.1016/j.ymgme.2013.02.013 DO - 10.1016/j.ymgme.2013.02.013 ID - Brands2013 ER - TY - JOUR AU - Jamiolkowski, D. AU - Kolker, S. AU - Glahn, E. M. AU - Baric, I. AU - Zeman, J. AU - Baumgartner, M. R. PY - 2016 DA - 2016// TI - Behavioural and emotional problems, intellectual impairment and health-related quality of life in patients with organic acidurias and urea cycle disorders JO - J Inherit Metab Dis VL - 39 UR - https://doi.org/10.1007/s10545-015-9887-8 DO - 10.1007/s10545-015-9887-8 ID - Jamiolkowski2016 ER - TY - JOUR AU - Okano, Y. AU - Kobayashi, K. AU - Ihara, K. AU - Ito, T. AU - Yoshino, M. AU - Watanabe, Y. PY - 2013 DA - 2013// TI - Fatigue and quality of life in citrin deficiency during adaptation and compensation stage JO - Mol Genet Metab VL - 109 UR - https://doi.org/10.1016/j.ymgme.2013.01.020 DO - 10.1016/j.ymgme.2013.01.020 ID - Okano2013 ER - TY - JOUR AU - Żuraw, W. AU - Golicki, D. AU - Jurecka, A. AU - Tylki-Szymańska, A. PY - 2011 DA - 2011// TI - Quality of life among polish Fabry patients — a cross-sectional study quality of life among polish Fabry patients JO - Open Med VL - 6 UR - https://doi.org/10.2478/s11536-011-0087-0 DO - 10.2478/s11536-011-0087-0 ID - Żuraw2011 ER - TY - JOUR AU - Miners, A. H. AU - Holmes, A. AU - Sherr, L. AU - Jenkinson, C. AU - MacDermot, K. D. PY - 2002 DA - 2002// TI - Assessment of health-related quality-of-life in males with Anderson Fabry disease before therapeutic intervention JO - Qual Life Res VL - 11 UR - https://doi.org/10.1023/A:1015009210639 DO - 10.1023/A:1015009210639 ID - Miners2002 ER - TY - JOUR AU - Wilcox, W. R. AU - Oliveira, J. P. AU - Hopkin, R. J. AU - Ortiz, A. AU - Banikazemi, M. AU - Feldt-Rasmussen, U. PY - 2008 DA - 2008// TI - Females with Fabry disease frequently have major organ involvement: lessons from the Fabry registry JO - Mol Genet Metab VL - 93 UR - https://doi.org/10.1016/j.ymgme.2007.09.013 DO - 10.1016/j.ymgme.2007.09.013 ID - Wilcox2008 ER - TY - JOUR AU - Bouwman, M. G. AU - Maurice-Stam, H. AU - Linthorst, G. E. AU - Hollak, C. E. M. AU - Wijburg, F. A. AU - Grootenhuis, M. A. PY - 2011 DA - 2011// TI - Impact of growing up with Fabry disease on achievement of psychosocial milestones and quality of life JO - Mol Genet Metab VL - 104 UR - https://doi.org/10.1016/j.ymgme.2011.07.006 DO - 10.1016/j.ymgme.2011.07.006 ID - Bouwman2011 ER - TY - JOUR AU - Oder, D. AU - Uceyler, N. AU - Liu, D. AU - Hu, K. AU - Petritsch, B. AU - Sommer, C. PY - 2016 DA - 2016// TI - Organ manifestations and long-term outcome of Fabry disease in patients with the GLA haplotype D313Y JO - BMJ Open VL - 6 UR - https://doi.org/10.1136/bmjopen-2015-010422 DO - 10.1136/bmjopen-2015-010422 ID - Oder2016 ER - TY - JOUR AU - Gold, K. F. AU - Pastores, G. M. AU - Botteman, M. F. AU - Yeh, J. M. AU - Sweeney, S. AU - Aliski, W. PY - 2002 DA - 2002// TI - Quality of life of patients with Fabry disease JO - Qual Life Res VL - 11 UR - https://doi.org/10.1023/A:1015511908710 DO - 10.1023/A:1015511908710 ID - Gold2002 ER - TY - JOUR AU - Street, N. J. AU - Yi, M. S. AU - Bailey, L. A. AU - Hopkin, R. J. PY - 2006 DA - 2006// TI - Comparison of health-related quality of life between heterozygous women with Fabry disease, a healthy control population, and patients with other chronic disease JO - Genet Med. VL - 8 UR - https://doi.org/10.1097/01.gim.0000223545.63012.5a DO - 10.1097/01.gim.0000223545.63012.5a ID - Street2006 ER - TY - JOUR AU - Hopkin, R. J. AU - Bissler, J. AU - Banikazemi, M. AU - Clarke, L. AU - Eng, C. M. AU - Germain, D. P. PY - 2008 DA - 2008// TI - Characterization of Fabry disease in 352 pediatric patients in the Fabry registry JO - Pediatr Res VL - 64 UR - https://doi.org/10.1203/PDR.0b013e318183f132 DO - 10.1203/PDR.0b013e318183f132 ID - Hopkin2008 ER - TY - JOUR AU - Weinreb, N. AU - Barranger, J. AU - Packman, S. AU - Prakash-Cheng, A. AU - Rosenbloom, B. AU - Sims, K. PY - 2007 DA - 2007// TI - Imiglucerase (Cerezyme) improves quality of life in patients with skeletal manifestations of Gaucher disease JO - Clin Genet VL - 71 UR - https://doi.org/10.1111/j.1399-0004.2007.00811.x DO - 10.1111/j.1399-0004.2007.00811.x ID - Weinreb2007 ER - TY - JOUR AU - Giraldo, P. AU - Solano, V. AU - Perez-Calvo, J. -. I. AU - Giralt, M. AU - Rubio-Felix, D. PY - 2005 DA - 2005// TI - Quality of life related to type 1 Gaucher disease: Spanish experience JO - Qual Life Res VL - 14 UR - https://doi.org/10.1007/s11136-004-0794-y DO - 10.1007/s11136-004-0794-y ID - Giraldo2005 ER - TY - JOUR AU - Hagemans, M. L. C. AU - Janssens, A. C. J. W. AU - Winkel, L. P. F. AU - Sieradzan, K. A. AU - Reuser, A. J. J. AU - Van Doorn, P. A. PY - 2004 DA - 2004// TI - Late-onset Pompe disease primarily affects quality of life in physical health domains JO - Neurology VL - 63 UR - https://doi.org/10.1212/01.WNL.0000142597.69707.78 DO - 10.1212/01.WNL.0000142597.69707.78 ID - Hagemans2004 ER - TY - JOUR AU - Gungor, D. AU - Schober, A. K. AU - Kruijshaar, M. E. AU - Plug, I. AU - Karabul, N. AU - Deschauer, M. PY - 2013 DA - 2013// TI - Pain in adult patients with Pompe disease: a cross-sectional survey JO - Mol Genet Metab VL - 109 UR - https://doi.org/10.1016/j.ymgme.2013.05.021 DO - 10.1016/j.ymgme.2013.05.021 ID - Gungor2013 ER - TY - JOUR AU - Gungor, D. AU - Kruijshaar, M. E. AU - Plug, I. AU - Rizopoulos, D. AU - Kanters, T. A. AU - Wens, S. C. A. PY - 2016 DA - 2016// TI - Quality of life and participation in daily life of adults with Pompe disease receiving enzyme replacement therapy: 10 years of international follow-up JO - J Inherit Metab Dis VL - 39 UR - https://doi.org/10.1007/s10545-015-9889-6 DO - 10.1007/s10545-015-9889-6 ID - Gungor2016 ER - TY - JOUR AU - van der Ploeg, A. T. AU - Clemens, P. R. AU - Corzo, D. AU - Escolar, D. M. AU - Florence, J. AU - Groeneveld, G. J. PY - 2010 DA - 2010// TI - A randomized study of Alglucosidase alfa in late-onset Pompe’s disease JO - N Engl J Med VL - 362 UR - https://doi.org/10.1056/NEJMoa0909859 DO - 10.1056/NEJMoa0909859 ID - van der Ploeg2010 ER - TY - JOUR AU - van der Hilst, J. C. H. AU - Bodar, E. J. AU - Barron, K. S. AU - Frenkel, J. AU - Drenth, J. P. H. AU - van der Meer, J. W. M. PY - 2008 DA - 2008// TI - Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome JO - Medicine (Baltimore) VL - 87 UR - https://doi.org/10.1097/MD.0b013e318190cfb7 DO - 10.1097/MD.0b013e318190cfb7 ID - van der Hilst2008 ER - TY - JOUR AU - Meiser, B. AU - Dunn, S. AU - Dixon, J. AU - Powell, L. W. PY - 2005 DA - 2005// TI - Psychological adjustment and knowledge about hereditary hemochromatosis in a clinic-based sample: a prospective study JO - J Genet Couns VL - 14 UR - https://doi.org/10.1007/s10897-005-6192-y DO - 10.1007/s10897-005-6192-y ID - Meiser2005 ER - TY - JOUR AU - Millward, L. M. AU - Kelly, P. AU - Deacon, A. AU - Senior, V. AU - Peters, T. J. PY - 2001 DA - 2001// TI - Self-rated psychosocial consequences and quality of life in the acute porphyrias JO - J Inherit Metab Dis VL - 24 UR - https://doi.org/10.1023/A:1012901607040 DO - 10.1023/A:1012901607040 ID - Millward2001 ER - TY - JOUR AU - Verhaak, C. AU - de Laat, P. AU - Koene, S. AU - Tibosch, M. AU - Rodenburg, R. AU - de Groot, I. PY - 2016 DA - 2016// TI - Quality of life, fatigue and mental health in patients with the m.3243A > G mutation and its correlates with genetic characteristics and disease manifestation JO - Orphanet J Rare Dis. VL - 11 UR - https://doi.org/10.1186/s13023-016-0403-5 DO - 10.1186/s13023-016-0403-5 ID - Verhaak2016 ER - TY - JOUR AU - Munguia-Izquierdo, D. AU - Santalla, A. AU - Lucia, A. PY - 2015 DA - 2015// TI - Cardiorespiratory fitness, physical activity, and quality of life in patients with McArdle disease JO - Med Sci Sports Exerc VL - 47 UR - https://doi.org/10.1249/MSS.0000000000000458 DO - 10.1249/MSS.0000000000000458 ID - Munguia-Izquierdo2015 ER - TY - JOUR AU - Ali, N. AU - Cagle, S. PY - 2015 DA - 2015// TI - Psychological health in adults with morquio syndrome JO - JIMD Rep. VL - 20 UR - https://doi.org/10.1007/8904_2014_396 DO - 10.1007/8904_2014_396 ID - Ali2015 ER - TY - JOUR AU - Koens, L. H. AU - Kuiper, A. AU - Coenen, M. A. AU - Elting, J. W. J. AU - de Vries, J. J. AU - Engelen, M. PY - 2016 DA - 2016// TI - Ataxia, dystonia and myoclonus in adult patients with Niemann-pick type C JO - Orphanet J Rare Dis. VL - 11 UR - https://doi.org/10.1186/s13023-016-0502-3 DO - 10.1186/s13023-016-0502-3 ID - Koens2016 ER - TY - JOUR AU - Che, H. AU - Roux, C. AU - Etcheto, A. AU - Rothenbuhler, A. AU - Kamenicky, P. AU - Linglart, A. PY - 2016 DA - 2016// TI - Impaired quality of life in adults with X-linked hypophosphatemia and skeletal symptoms JO - Eur J Endocrinol VL - 174 UR - https://doi.org/10.1530/EJE-15-0661 DO - 10.1530/EJE-15-0661 ID - Che2016 ER - TY - JOUR AU - Arends, M. AU - Korver, S. AU - Hughes, D. A. AU - Mehta, A. AU - Hollak, C. E. M. AU - Biegstraaten, M. PY - 2017 DA - 2017// TI - Phenotype, disease severity and pain are major determinants of quality of life in Fabry disease: results from a large multicenter cohort study JO - J Inherit Metab Dis VL - 41 UR - https://doi.org/10.1007/s10545-017-0095-6 DO - 10.1007/s10545-017-0095-6 ID - Arends2017 ER - TY - JOUR AU - Kanters, T. A. AU - Hagemans, M. L. C. AU - van der Beek, N. A. M. E. AU - Rutten, F. F. H. AU - van der Ploeg, A. T. AU - Hakkaart, L. PY - 2011 DA - 2011// TI - Burden of illness of Pompe disease in patients only receiving supportive care JO - J Inherit Metab Dis VL - 34 UR - https://doi.org/10.1007/s10545-011-9320-x DO - 10.1007/s10545-011-9320-x ID - Kanters2011 ER - TY - JOUR AU - Hendriksz, C. J. AU - Lavery, C. AU - Coker, M. AU - Ucar, S. K. AU - Jain, M. AU - Bell, L. PY - 2014 DA - 2014// TI - Burden of disease in patients with Morquio A syndrome: results from an international patient-reported outcomes survey JO - Orphanet J Rare Dis VL - 9 UR - https://doi.org/10.1186/1750-1172-9-32 DO - 10.1186/1750-1172-9-32 ID - Hendriksz2014 ER - TY - JOUR AU - Guffon, N. AU - Heron, B. AU - Chabrol, B. AU - Feillet, F. AU - Montauban, V. AU - Valayannopoulos, V. PY - 2015 DA - 2015// TI - Diagnosis, quality of life, and treatment of patients with hunter syndrome in the French healthcare system: a retrospective observational study JO - Orphanet J Rare Dis. VL - 10 UR - https://doi.org/10.1186/s13023-015-0259-0 DO - 10.1186/s13023-015-0259-0 ID - Guffon2015 ER - TY - JOUR AU - Bosch, A. M. AU - Grootenhuis, M. A. AU - Bakker, H. D. AU - Heijmans, H. S. A. AU - Wijburg, F. A. AU - Last, B. F. PY - 2004 DA - 2004// TI - Living with classical Galactosemia: health-related quality of life consequences JO - Pediatrics VL - 113 UR - https://doi.org/10.1542/peds.113.5.e423 DO - 10.1542/peds.113.5.e423 ID - Bosch2004 ER - TY - JOUR AU - Hoffmann, B. AU - Dragano, N. AU - Schweitzer-Krantz, S. PY - 2012 DA - 2012// TI - Living situation, occupation and health-related quality of life in adult patients with classic galactosemia JO - J Inherit Metab Dis VL - 35 UR - https://doi.org/10.1007/s10545-012-9469-y DO - 10.1007/s10545-012-9469-y ID - Hoffmann2012 ER - TY - JOUR AU - Weber, T. J. AU - Sawyer, E. K. AU - Moseley, S. AU - Odrljin, T. AU - Kishnani, P. S. PY - 2016 DA - 2016// TI - Burden of disease in adult patients with hypophosphatasia: results from two patient-reported surveys JO - Metabolism VL - 65 UR - https://doi.org/10.1016/j.metabol.2016.07.006 DO - 10.1016/j.metabol.2016.07.006 ID - Weber2016 ER - TY - JOUR AU - Maia, M. AU - Volpini, B. M. F. AU - dos Santos, G. A. AU - Rujula, M. J. P. PY - 2015 DA - 2015// TI - Quality of life in patients with oculocutaneous albinism JO - An Bras Dermatol VL - 90 UR - https://doi.org/10.1590/abd1806-4841.20153498 DO - 10.1590/abd1806-4841.20153498 ID - Maia2015 ER - TY - JOUR AU - Ries, M. AU - Gupta, S. AU - Moore, D. F. AU - Sachdev, V. AU - Quirk, J. M. AU - Murray, G. J. PY - 2005 DA - 2005// TI - Pediatric Fabry disease JO - Pediatrics VL - 115 UR - https://doi.org/10.1542/peds.2004-1678 DO - 10.1542/peds.2004-1678 ID - Ries2005 ER - TY - JOUR AU - Bugescu, N. AU - Naylor, P. E. AU - Hudson, K. AU - Aoki, C. D. AU - Cordova, M. J. AU - Packman, W. PY - 2016 DA - 2016// TI - The psychosocial impact of Fabry disease on pediatric patients JO - J Pediatr Genet VL - 5 UR - https://doi.org/10.1055/s-0036-1584357 DO - 10.1055/s-0036-1584357 ID - Bugescu2016 ER - TY - JOUR AU - Neto, E. V. AU - Maia Filho, H. S. AU - Monteiro, C. B. AU - Carvalho, L. M. AU - Tonon, T. AU - Vanz, A. P. PY - 2017 DA - 2017// TI - Quality of life and adherence to treatment in early-treated Brazilian phenylketonuria pediatric patients JO - Brazilian J Med Biol Res VL - 51 ID - Neto2017 ER - TY - JOUR AU - Guran, T. AU - Arman, A. AU - Akcay, T. AU - Kayan, E. AU - Atay, Z. AU - Turan, S. PY - 2011 DA - 2011// TI - Cognitive and psychosocial development in children with familial hypomagnesaemia JO - Magnes Res VL - 24 ID - Guran2011 ER - TY - JOUR AU - Ulmer, F. F. AU - Landolt, M. A. AU - Ha Vinh, R. AU - Huisman, T. A. G. M. AU - Neuhaus, T. J. AU - Latal, B. PY - 2009 DA - 2009// TI - Intellectual and motor performance, quality of life and psychosocial adjustment in children with cystinosis JO - Pediatr Nephrol VL - 24 UR - https://doi.org/10.1007/s00467-009-1149-2 DO - 10.1007/s00467-009-1149-2 ID - Ulmer2009 ER - TY - JOUR AU - Wagner, M. AU - Kramer, J. AU - Blohm, E. AU - Vergho, D. AU - Weidemann, F. AU - Breunig, F. PY - 2014 DA - 2014// TI - Kidney function as an underestimated factor for reduced health related quality of life in patients with Fabry disease JO - BMC Nephrol VL - 15 UR - https://doi.org/10.1186/1471-2369-15-188 DO - 10.1186/1471-2369-15-188 ID - Wagner2014 ER - TY - JOUR AU - Hoffmann, B. AU - Keshav, S. PY - 2007 DA - 2007// TI - Gastrointestinal symptoms in Fabry disease: everything is possible, including treatment JO - Acta Paediatr VL - 96 UR - https://doi.org/10.1111/j.1651-2227.2007.00216.x DO - 10.1111/j.1651-2227.2007.00216.x ID - Hoffmann2007 ER - TY - STD TI - Bosch AM, Burlina A, Cunningham A, Bettiol E, Moreau-Stucker F, Koledova E, et al. Assessment of the impact of phenylketonuria and its treatment on quality of life of patients and parents from seven European countries. Orphanet J Rare Dis. 2015;10:80. ID - ref89 ER - TY - JOUR AU - Lampe, C. AU - Jain, M. AU - Olaye, A. AU - Meesen, B. AU - Decker, C. AU - Mengel, E. PY - 2015 DA - 2015// TI - Relationship between patient-reported outcomes and clinical outcomes in patients with Morquio a syndrome JO - J Inborn Errors Metab Screen VL - 3 UR - https://doi.org/10.1177/2326409815576188 DO - 10.1177/2326409815576188 ID - Lampe2015 ER - TY - JOUR AU - Mata, N. AU - Alonso, R. AU - Banegas, J. R. AU - Zambon, D. AU - Brea, A. AU - Mata, P. PY - 2012 DA - 2012// TI - Quality of life in a cohort of familial hypercholesterolemia patients from the south of Europe JO - Eur J Pub Health VL - 24 UR - https://doi.org/10.1093/eurpub/cks174 DO - 10.1093/eurpub/cks174 ID - Mata2012 ER - TY - JOUR AU - Wyatt, K. AU - Henley, W. AU - Anderson, L. AU - Anderson, R. AU - Nikolaou, V. AU - Stein, K. PY - 2012 DA - 2012// TI - The effectiveness and cost-effectiveness of enzyme and substrate replacement therapies: a longitudinal cohort study of people with lysosomal storage disorders JO - Health Technol Assess VL - 16 UR - https://doi.org/10.3310/hta16390 DO - 10.3310/hta16390 ID - Wyatt2012 ER - TY - JOUR AU - Simon, E. AU - Schwarz, M. AU - Roos, J. AU - Dragano, N. AU - Geraedts, M. AU - Siegrist, J. PY - 2008 DA - 2008// TI - Evaluation of quality of life and description of the sociodemographic state in adolescent and young adult patients with phenylketonuria (PKU) JO - Health Qual Life Outcomes VL - 6 UR - https://doi.org/10.1186/1477-7525-6-25 DO - 10.1186/1477-7525-6-25 ID - Simon2008 ER - TY - JOUR AU - Bosch, A. M. AU - Tybout, W. AU - van Spronsen, F. J. AU - de Valk, H. W. AU - Wijburg, F. A. AU - Grootenhuis, M. A. PY - 2007 DA - 2007// TI - The course of life and quality of life of early and continuously treated Dutch patients with phenylketonuria JO - J Inherit Metab Dis VL - 30 UR - https://doi.org/10.1007/s10545-006-0433-6 DO - 10.1007/s10545-006-0433-6 ID - Bosch2007 ER - TY - JOUR AU - Hyttinen, L. AU - Kekalainen, P. AU - Vuorio, A. F. AU - Sintonen, H. AU - Strandberg, T. E. PY - 2008 DA - 2008// TI - Health-related quality of life in elderly patients with familial hypercholesterolemia JO - Int J Technol Assess Health Care VL - 24 UR - https://doi.org/10.1017/S0266462308080318 DO - 10.1017/S0266462308080318 ID - Hyttinen2008 ER - TY - JOUR AU - de Jongh, S. AU - Kerckhoffs, M. C. AU - Grootenhuis, M. A. AU - Bakker, H. D. AU - Heymans, H. S. A. AU - Last, B. F. PY - 2003 DA - 2003// TI - Quality of life, anxiety and concerns among statin-treated children with familial hypercholesterolaemia and their parents JO - Acta Paediatr VL - 92 UR - https://doi.org/10.1111/j.1651-2227.2003.tb02584.x DO - 10.1111/j.1651-2227.2003.tb02584.x ID - de Jongh2003 ER - TY - JOUR AU - Grunert, S. C. AU - Mullerleile, S. AU - De Silva, L. AU - Barth, M. AU - Walter, M. AU - Walter, K. PY - 2013 DA - 2013// TI - Propionic acidemia: clinical course and outcome in 55 pediatric and adolescent patients JO - Orphanet J Rare Dis. VL - 8 UR - https://doi.org/10.1186/1750-1172-8-6 DO - 10.1186/1750-1172-8-6 ID - Grunert2013 ER - TY - JOUR AU - Giraldo, P. AU - Latre, P. AU - Alfonso, P. AU - Acedo, A. AU - Alonso, D. AU - Barez, A. PY - 2006 DA - 2006// TI - Short-term effect of miglustat in every day clinical use in treatment-naive or previously treated patients with type 1 Gaucher’s disease JO - Haematologica VL - 91 ID - Giraldo2006 ER - TY - JOUR AU - Giraldo, P. AU - Perez-Lopez, J. AU - Nunez, R. AU - de la Puebla, R. F. AU - Luno, E. AU - Saura-Grau, S. PY - 2016 DA - 2016// TI - Patients with type 1 Gaucher disease in Spain: a cross-sectional evaluation of health status JO - Blood Cells Mol Dis VL - 56 UR - https://doi.org/10.1016/j.bcmd.2015.10.001 DO - 10.1016/j.bcmd.2015.10.001 ID - Giraldo2016 ER - TY - JOUR AU - Martinuzzi, A. AU - Liava, A. AU - Trevisi, E. AU - Frare, M. AU - Tonon, C. AU - Malucelli, E. PY - 2008 DA - 2008// TI - Randomized, placebo-controlled, double-blind pilot trial of ramipril in McArdle’s disease JO - Muscle Nerve VL - 37 UR - https://doi.org/10.1002/mus.20937 DO - 10.1002/mus.20937 ID - Martinuzzi2008 ER - TY - JOUR AU - Martinuzzi, A. AU - Liava, A. AU - Trevisi, E. AU - Antoniazzi, L. AU - Frare, M. PY - 2007 DA - 2007// TI - Chronic therapy for McArdle disease: the randomized trial with ACE inhibitor JO - Acta Myol VL - 26 ID - Martinuzzi2007 ER - TY - JOUR AU - Vielhaber, S. AU - Brejova, A. AU - Debska-Vielhaber, G. AU - Kaufmann, J. AU - Feistner, H. AU - Schoenfeld, M. A. PY - 2011 DA - 2011// TI - 24-months results in two adults with Pompe disease on enzyme replacement therapy JO - Clin Neurol Neurosurg VL - 113 UR - https://doi.org/10.1016/j.clineuro.2010.09.016 DO - 10.1016/j.clineuro.2010.09.016 ID - Vielhaber2011 ER - TY - JOUR AU - Orlikowski, D. AU - Pellegrini, N. AU - Prigent, H. AU - Laforêt, P. AU - Carlier, R. AU - Carlier, P. PY - 2011 DA - 2011// TI - Recombinant human acid alpha-glucosidase (rhGAA) in adult patients with severe respiratory failure due to Pompe disease JO - Neuromuscul Disord VL - 21 UR - https://doi.org/10.1016/j.nmd.2011.04.001 DO - 10.1016/j.nmd.2011.04.001 ID - Orlikowski2011 ER - TY - JOUR AU - Mundy, H. R. AU - Williams, J. E. AU - Cousins, A. J. AU - Lee, P. J. PY - 2006 DA - 2006// TI - The effect of L-alanine therapy in a patient with adult onset glycogen storage disease type II JO - J Inherit Metab Dis VL - 29 UR - https://doi.org/10.1007/s10545-006-0238-7 DO - 10.1007/s10545-006-0238-7 ID - Mundy2006 ER - TY - JOUR AU - Favejee, M. M. AU - van den Berg, L. E. M. AU - Kruijshaar, M. E. AU - Wens, S. C. A. AU - Praet, S. F. E. AU - Pim Pijnappel, W. W. M. PY - 2015 DA - 2015// TI - Exercise training in adults with Pompe disease: the effects on pain, fatigue, and functioning JO - Arch Phys Med Rehabil VL - 96 UR - https://doi.org/10.1016/j.apmr.2014.11.020 DO - 10.1016/j.apmr.2014.11.020 ID - Favejee2015 ER - TY - JOUR AU - Roe, C. R. AU - Mochel, F. PY - 2006 DA - 2006// TI - Anaplerotic diet therapy in inherited metabolic disease: therapeutic potential JO - J Inherit Metab Dis VL - 29 UR - https://doi.org/10.1007/s10545-006-0290-3 DO - 10.1007/s10545-006-0290-3 ID - Roe2006 ER - TY - JOUR AU - Eng, C. M. AU - Guffon, N. AU - Wilcox, W. R. AU - Germain, D. P. AU - Lee, P. AU - Waldek, S. PY - 2001 DA - 2001// TI - Safety and efficacy of recombinant human alpha-galactosidase a replacement therapy in Fabry’s disease JO - N Engl J Med VL - 345 UR - https://doi.org/10.1056/NEJM200107053450102 DO - 10.1056/NEJM200107053450102 ID - Eng2001 ER - TY - JOUR AU - Eng, C. M. AU - Banikazemi, M. AU - Gordon, R. E. AU - Goldman, M. AU - Phelps, R. AU - Kim, L. PY - 2001 DA - 2001// TI - A phase 1/2 clinical trial of enzyme replacement in fabry disease: pharmacokinetic, substrate clearance, and safety studies JO - Am J Hum Genet VL - 68 UR - https://doi.org/10.1086/318809 DO - 10.1086/318809 ID - Eng2001 ER - TY - JOUR AU - Watt, T. AU - Burlina, A. P. AU - Cazzorla, C. AU - Schonfeld, D. AU - Banikazemi, M. AU - Hopkin, R. J. PY - 2010 DA - 2010// TI - Agalsidase beta treatment is associated with improved quality of life in patients with Fabry disease: findings from the Fabry registry JO - Genet Med. VL - 12 UR - https://doi.org/10.1097/GIM.0b013e3181f13a4a DO - 10.1097/GIM.0b013e3181f13a4a ID - Watt2010 ER - TY - JOUR AU - Eto, Y. AU - Ohashi, T. AU - Utsunomiya, Y. AU - Fujiwara, M. AU - Mizuno, A. AU - Inui, K. PY - 2005 DA - 2005// TI - Enzyme replacement therapy in Japanese Fabry disease patients: the results of a phase 2 bridging study JO - J Inherit Metab Dis VL - 28 UR - https://doi.org/10.1007/s10545-005-0575-y DO - 10.1007/s10545-005-0575-y ID - Eto2005 ER - TY - JOUR AU - Baehner, F. AU - Kampmann, C. AU - Whybra, C. AU - Miebach, E. AU - Wiethoff, C. M. AU - Beck, M. PY - 2003 DA - 2003// TI - Enzyme replacement therapy in heterozygous females with Fabry disease: results of a phase IIIB study JO - J Inherit Metab Dis VL - 26 UR - https://doi.org/10.1023/B:BOLI.0000005658.14563.77 DO - 10.1023/B:BOLI.0000005658.14563.77 ID - Baehner2003 ER - TY - JOUR AU - Graesdal, A. AU - Bogsrud, M. P. AU - Holven, K. B. AU - Nenseter, M. S. AU - Narverud, I. AU - Langslet, G. PY - 2012 DA - 2012// TI - Apheresis in homozygous familial hypercholesterolemia: the results of a follow-up of all Norwegian patients with homozygous familial hypercholesterolemia JO - J Clin Lipidol VL - 6 UR - https://doi.org/10.1016/j.jacl.2012.03.004 DO - 10.1016/j.jacl.2012.03.004 ID - Graesdal2012 ER - TY - JOUR AU - Elstein, D. AU - Dweck, A. AU - Attias, D. AU - Hadas-Halpern, I. AU - Zevin, S. AU - Altarescu, G. PY - 2007 DA - 2007// TI - Oral maintenance clinical trial with miglustat for type I Gaucher disease: switch from or combination with intravenous enzyme replacement JO - Blood VL - 110 UR - https://doi.org/10.1182/blood-2007-02-075960 DO - 10.1182/blood-2007-02-075960 ID - Elstein2007 ER - TY - JOUR AU - Giraldo, P. AU - Alfonso, P. AU - Atutxa, K. AU - Fernandez-Galan, M. A. AU - Barez, A. AU - Franco, R. PY - 2009 DA - 2009// TI - Real-world clinical experience with long-term miglustat maintenance therapy in type 1 Gaucher disease: the ZAGAL project JO - Haematologica VL - 94 UR - https://doi.org/10.3324/haematol.2009.008078 DO - 10.3324/haematol.2009.008078 ID - Giraldo2009 ER - TY - JOUR AU - Harmatz, P. R. AU - Mengel, E. AU - Geberhiwot, T. AU - Muschol, N. AU - Hendriksz, C. J. AU - Burton, B. K. PY - 2017 DA - 2017// TI - Impact of elosulfase alfa in patients with morquio a syndrome who have limited ambulation: an open-label, phase 2 study JO - Am J Med Genet A VL - 173 UR - https://doi.org/10.1002/ajmg.a.38014 DO - 10.1002/ajmg.a.38014 ID - Harmatz2017 ER - TY - JOUR AU - Sutcliffe, R. P. AU - Maguire, D. D. AU - Muiesan, P. AU - Dhawan, A. AU - Mieli-Vergani, G. AU - O’Grady, J. G. PY - 2003 DA - 2003// TI - Liver transplantation for Wilson’s disease: long-term results and quality-of-life assessment JO - Transplantation VL - 75 UR - https://doi.org/10.1097/01.TP.0000055830.82799.B1 DO - 10.1097/01.TP.0000055830.82799.B1 ID - Sutcliffe2003 ER - TY - JOUR AU - Regnery, C. AU - Kornblum, C. AU - Hanisch, F. AU - Vielhaber, S. AU - Strigl-Pill, N. AU - Grunert, B. PY - 2012 DA - 2012// TI - 36 months observational clinical study of 38 adult Pompe disease patients under alglucosidase alfa enzyme replacement therapy JO - J Inherit Metab Dis VL - 35 UR - https://doi.org/10.1007/s10545-012-9451-8 DO - 10.1007/s10545-012-9451-8 ID - Regnery2012 ER - TY - JOUR AU - Strothotte, S. AU - Strigl-Pill, N. AU - Grunert, B. AU - Kornblum, C. AU - Eger, K. AU - Wessig, C. PY - 2010 DA - 2010// TI - Enzyme replacement therapy with alglucosidase alfa in 44 patients with late-onset glycogen storage disease type 2: 12-month results of an observational clinical trial JO - J Neurol VL - 257 UR - https://doi.org/10.1007/s00415-009-5275-3 DO - 10.1007/s00415-009-5275-3 ID - Strothotte2010 ER - TY - JOUR AU - Aslan, G. K. AU - Huseyinsinoglu, B. E. AU - Oflazer, P. AU - Gurses, N. AU - Kiyan, E. PY - 2016 DA - 2016// TI - Inspiratory muscle training in late-onset Pompe disease: the effects on pulmonary function tests, quality of life, and sleep quality JO - Lung VL - 194 UR - https://doi.org/10.1007/s00408-016-9881-4 DO - 10.1007/s00408-016-9881-4 ID - Aslan2016 ER - TY - JOUR AU - Beck, M. AU - Ricci, R. AU - Widmer, U. AU - Dehout, F. AU - de Lorenzo, A. G. AU - Kampmann, C. PY - 2004 DA - 2004// TI - Fabry disease: overall effects of agalsidase alfa treatment JO - Eur J Clin Investig VL - 34 UR - https://doi.org/10.1111/j.1365-2362.2004.01424.x DO - 10.1111/j.1365-2362.2004.01424.x ID - Beck2004 ER - TY - JOUR AU - Mehta, A. AU - Beck, M. AU - Elliott, P. AU - Giugliani, R. AU - Linhart, A. AU - Sunder-Plassmann, G. AU - Schiffmann, R. AU - Barbey, F. AU - Ries, M. AU - Clarke, J. T. R. PY - 2009 DA - 2009// TI - Enzyme replacement therapy with agalsidase alfa in patients with Fabry's disease: an analysis of registry data JO - The Lancet VL - 374 UR - https://doi.org/10.1016/S0140-6736(09)61493-8 DO - 10.1016/S0140-6736(09)61493-8 ID - Mehta2009 ER - TY - JOUR AU - Hoffmann, B. AU - Garcia de Lorenzo, A. AU - Mehta, A. AU - Beck, M. AU - Widmer, U. AU - Ricci, R. PY - 2005 DA - 2005// TI - Effects of enzyme replacement therapy on pain and health related quality of life in patients with Fabry disease: data from FOS (Fabry Outcome Survey) JO - J Med Genet VL - 42 UR - https://doi.org/10.1136/jmg.2004.025791 DO - 10.1136/jmg.2004.025791 ID - Hoffmann2005 ER - TY - JOUR AU - Langman, C. B. AU - Greenbaum, L. A. AU - Grimm, P. AU - Sarwal, M. AU - Niaudet, P. AU - Deschenes, G. PY - 2014 DA - 2014// TI - Quality of life is improved and kidney function preserved in patients with nephropathic cystinosis treated for 2 years with delayed-release cysteamine bitartrate JO - J Pediatr VL - 165 UR - https://doi.org/10.1016/j.jpeds.2014.05.013 DO - 10.1016/j.jpeds.2014.05.013 ID - Langman2014 ER - TY - JOUR AU - Douglas, T. D. AU - Ramakrishnan, U. AU - Kable, J. A. AU - Singh, R. H. PY - 2013 DA - 2013// TI - Longitudinal quality of life analysis in a phenylketonuria cohort provided sapropterin dihydrochloride JO - Health Qual Life Outcomes VL - 11 UR - https://doi.org/10.1186/1477-7525-11-218 DO - 10.1186/1477-7525-11-218 ID - Douglas2013 ER - TY - JOUR AU - Cazzorla, C. AU - Del Rizzo, M. AU - Burgard, P. AU - Zanco, C. AU - Bordugo, A. AU - Burlina, A. B. PY - 2012 DA - 2012// TI - Application of the WHOQOL-100 for the assessment of quality of life of adult patients with inherited metabolic diseases JO - Mol Genet Metab VL - 106 UR - https://doi.org/10.1016/j.ymgme.2012.02.008 DO - 10.1016/j.ymgme.2012.02.008 ID - Cazzorla2012 ER - TY - JOUR AU - Gargiulo, M. AU - Herson, A. AU - Michon, C. C. AU - Hogrel, J. Y. AU - Doppler, V. AU - Laloui, K. PY - 2013 DA - 2013// TI - Attitudes and expectations of patients with neuromuscular diseases about their participation in a clinical trial JO - Rev Neurol (Paris) VL - 169 UR - https://doi.org/10.1016/j.neurol.2013.04.005 DO - 10.1016/j.neurol.2013.04.005 ID - Gargiulo2013 ER - TY - JOUR AU - Tsuboi, K. AU - Yamamoto, H. PY - 2014 DA - 2014// TI - Clinical course of patients with Fabry disease who were switched from agalsidase-beta to agalsidase-alpha JO - Genet Med VL - 16 UR - https://doi.org/10.1038/gim.2014.28 DO - 10.1038/gim.2014.28 ID - Tsuboi2014 ER - TY - CHAP AU - Oliveira, F. L. AU - Alegra, T. AU - Dornelles, A. AU - Krug, B. C. AU - Netto, C. B. O. AU - da Rocha, N. S. PY - 2012 DA - 2012// TI - Quality of life of Brazilian patients with Gaucher disease and Fabry disease BT - JIMD reports ID - Oliveira2012 ER - TY - JOUR AU - Hughes, D. A. AU - Deegan, P. B. AU - Milligan, A. AU - Wright, N. AU - Butler, L. H. AU - Jacobs, A. PY - 2013 DA - 2013// TI - A randomised, double-blind, placebo-controlled, crossover study to assess the efficacy and safety of three dosing schedules of agalsidase alfa enzyme replacement therapy for Fabry disease JO - Mol Genet Metab VL - 109 UR - https://doi.org/10.1016/j.ymgme.2013.04.015 DO - 10.1016/j.ymgme.2013.04.015 ID - Hughes2013 ER - TY - CHAP AU - Pisani, A. AU - Spinelli, L. AU - Visciano, B. AU - Capuano, I. AU - Sabbatini, M. AU - Riccio, E. PY - 2012 DA - 2012// TI - Effects of switching from Agalsidase Beta to Agalsidase alfa in 10 patients with Anderson-Fabry disease BT - JIMD reports ID - Pisani2012 ER - TY - JOUR AU - Kanters, T. A. AU - Redekop, W. K. AU - Kruijshaar, M. E. AU - van der Ploeg, A. T. AU - Rutten-van Molken, M. P. M. H. AU - Hakkaart, L. PY - 2015 DA - 2015// TI - Comparison of EQ-5D and SF-6D utilities in Pompe disease JO - Qual Life Res VL - 24 UR - https://doi.org/10.1007/s11136-014-0833-2 DO - 10.1007/s11136-014-0833-2 ID - Kanters2015 ER - TY - JOUR AU - Smid, B. E. AU - Rombach, S. M. AU - Aerts, J. M. F. G. AU - Kuiper, S. AU - Mirzaian, M. AU - Overkleeft, H. S. PY - 2011 DA - 2011// TI - Consequences of a global enzyme shortage of agalsidase beta in adult Dutch Fabry patients JO - Orphanet J Rare Dis. VL - 6 UR - https://doi.org/10.1186/1750-1172-6-69 DO - 10.1186/1750-1172-6-69 ID - Smid2011 ER - TY - JOUR AU - Bik-Multanowski, M. AU - Didycz, B. AU - Mozrzymas, R. AU - Nowacka, M. AU - Kaluzny, L. AU - Cichy, W. PY - 2008 DA - 2008// TI - Quality of life in noncompliant adults with phenylketonuria after resumption of the diet JO - J Inherit Metab Dis VL - 31 UR - https://doi.org/10.1007/s10545-008-0978-7 DO - 10.1007/s10545-008-0978-7 ID - Bik-Multanowski2008 ER - TY - JOUR AU - Muenzer, J. AU - Beck, M. AU - Eng, C. M. AU - Giugliani, R. AU - Harmatz, P. AU - Martin, R. PY - 2011 DA - 2011// TI - Long-term, open-labeled extension study of idursulfase in the treatment of hunter syndrome JO - Genet Med. VL - 13 UR - https://doi.org/10.1097/GIM.0b013e3181fea459 DO - 10.1097/GIM.0b013e3181fea459 ID - Muenzer2011 ER - TY - JOUR AU - Tsuboi, K. AU - Yamamoto, H. PY - 2012 DA - 2012// TI - Clinical observation of patients with Fabry disease after switching from agalsidase beta (Fabrazyme) to agalsidase alfa (Replagal) JO - Genet Med. VL - 14 UR - https://doi.org/10.1038/gim.2012.39 DO - 10.1038/gim.2012.39 ID - Tsuboi2012 ER - TY - JOUR AU - Wild, D. AU - Eremenco, S. AU - Mear, I. AU - Martin, M. AU - Houchin, C. AU - Gawlicki, M. PY - 2009 DA - 2009// TI - Multinational trials—recommendations on the translations required, approaches to using the same language in different countries, and the approaches to support pooling the data: the ISPOR patient-reported outcomes translation and linguistic validation good research practices task force report JO - Value Heal VL - 12 UR - https://doi.org/10.1111/j.1524-4733.2008.00471.x DO - 10.1111/j.1524-4733.2008.00471.x ID - Wild2009 ER - TY - JOUR AU - Sechi, A. AU - Deroma, L. AU - Paci, S. AU - Lapolla, A. AU - Carubbi, F. AU - Burlina, A. PY - 2014 DA - 2014// TI - Quality of life in adult patients with glycogen storage disease type I: results of a multicenter italian study JO - JIMD Rep VL - 14 UR - https://doi.org/10.1007/8904_2013_283 DO - 10.1007/8904_2013_283 ID - Sechi2014 ER - TY - JOUR AU - Clarke, L. A. AU - Wraith, J. E. AU - Beck, M. AU - Kolodny, E. H. AU - Pastores, G. M. AU - Muenzer, J. PY - 2009 DA - 2009// TI - Long-term efficacy and safety of laronidase in the treatment of mucopolysaccharidosis I JO - Pediatrics VL - 123 UR - https://doi.org/10.1542/peds.2007-3847 DO - 10.1542/peds.2007-3847 ID - Clarke2009 ER - TY - JOUR AU - Gunther, P. AU - Hermann, W. AU - Kuhn, H. -. J. AU - Wagner, A. PY - 2007 DA - 2007// TI - Wilson’s disease JO - Ther Umsch VL - 64 UR - https://doi.org/10.1024/0040-5930.64.1.57 DO - 10.1024/0040-5930.64.1.57 ID - Gunther2007 ER - TY - JOUR AU - Schaefer, M. AU - Gotthardt, D. N. AU - Ganion, N. AU - Wohnsland, S. AU - Seessle, J. AU - Stremmel, W. PY - 2016 DA - 2016// TI - Wilson disease: health-related quality of life and risk for depression JO - Clin Res Hepatol Gastroenterol VL - 40 UR - https://doi.org/10.1016/j.clinre.2015.09.007 DO - 10.1016/j.clinre.2015.09.007 ID - Schaefer2016 ER - TY - JOUR AU - Koskenvuo, J. W. AU - Hartiala, J. J. AU - Nuutila, P. AU - Kalliokoski, R. AU - Viikari, J. S. AU - Engblom, E. PY - 2008 DA - 2008// TI - Twenty-four-month alpha-galactosidase a replacement therapy in Fabry disease has only minimal effects on symptoms and cardiovascular parameters JO - J Inherit Metab Dis VL - 31 UR - https://doi.org/10.1007/s10545-008-0848-3 DO - 10.1007/s10545-008-0848-3 ID - Koskenvuo2008 ER - TY - STD TI - Elfil M, Negida A. Sampling methods in Clinical Research; an Educational Review. Emerg (Tehran, Iran). 2017;5:e52. ID - ref142 ER - TY - JOUR AU - Modersitzki, F. AU - Pizzi, L. AU - Grasso, M. AU - Goldfarb, D. S. PY - 2014 DA - 2014// TI - Health-related quality of life (HRQoL) in cystine compared with non-cystine stone formers JO - Urolithiasis VL - 42 UR - https://doi.org/10.1007/s00240-013-0621-4 DO - 10.1007/s00240-013-0621-4 ID - Modersitzki2014 ER - TY - JOUR AU - de Graaff, B. AU - Neil, A. AU - Sanderson, K. AU - Yee, K. C. AU - Palmer, A. J. PY - 2016 DA - 2016// TI - Quality of life utility values for hereditary haemochromatosis in Australia JO - Health Qual Life Outcomes VL - 14 UR - https://doi.org/10.1186/s12955-016-0431-9 DO - 10.1186/s12955-016-0431-9 ID - de Graaff2016 ER - TY - JOUR AU - Laney, D. A. AU - Gruskin, D. J. AU - Fernhoff, P. M. AU - Cubells, J. F. AU - Ousley, O. Y. AU - Hipp, H. PY - 2010 DA - 2010// TI - Social-adaptive and psychological functioning of patients affected by Fabry disease JO - J Inherit Metab Dis VL - 33 UR - https://doi.org/10.1007/s10545-009-9025-6 DO - 10.1007/s10545-009-9025-6 ID - Laney2010 ER - TY - JOUR AU - Péntek, M. AU - Gulácsi, L. AU - Brodszky, V. AU - Baji, P. AU - Boncz, I. AU - Pogány, G. PY - 2016 DA - 2016// TI - Social/economic costs and health-related quality of life of mucopolysaccharidosis patients and their caregivers in Europe JO - Eur J Health Econ VL - 17 UR - https://doi.org/10.1007/s10198-016-0787-0 DO - 10.1007/s10198-016-0787-0 ID - Péntek2016 ER - TY - CHAP AU - Ghali, J. AU - Nicholls, K. AU - Denaro, C. AU - Sillence, D. AU - Chapman, I. AU - Goldblatt, J. PY - 2011 DA - 2011// TI - Effect of reduced Agalsidase Beta dosage in Fabry patients: the Australian experience BT - JIMD reports ID - Ghali2011 ER - TY - JOUR AU - Ware, J. E. AU - Sherbourne, C. D. PY - 1992 DA - 1992// TI - The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection JO - Med Care VL - 30 UR - https://doi.org/10.1097/00005650-199206000-00002 DO - 10.1097/00005650-199206000-00002 ID - Ware1992 ER - TY - JOUR AU - Wiebe, S. AU - Guyatt, G. AU - Weaver, B. AU - Matijevic, S. AU - Sidwell, C. PY - 2003 DA - 2003// TI - Comparative responsiveness of generic and specific quality-of-life instruments JO - J Clin Epidemiol VL - 56 UR - https://doi.org/10.1016/S0895-4356(02)00537-1 DO - 10.1016/S0895-4356(02)00537-1 ID - Wiebe2003 ER - TY - JOUR AU - Assari, S. AU - Lankarani, M. M. AU - Montazeri, A. AU - Soroush, M. R. AU - Mousavi, B. PY - 2009 DA - 2009// TI - Are generic and disease-specific health related quality of life correlated? The case of chronic lung disease due to sulfur mustard JO - J Res Med Sci VL - 14 ID - Assari2009 ER - TY - JOUR AU - Malý, M. AU - Vondra, V. PY - 2006 DA - 2006// TI - Generic versus disease-specific instruments in quality-of-life assessment of chronic obstructive pulmonary disease JO - Methods Inf Med VL - 45 UR - https://doi.org/10.1055/s-0038-1634053 DO - 10.1055/s-0038-1634053 ID - Malý2006 ER - TY - JOUR AU - Zeltner, N. A. AU - Baumgartner, M. R. AU - Bondarenko, A. AU - Ensenauer, R. AU - Karall, D. AU - Kolker, S. PY - 2017 DA - 2017// TI - Development and psychometric evaluation of the MetabQoL 1.0: a quality of life questionnaire for Paediatric patients with intoxication-type inborn errors of metabolism JO - JIMD Rep. VL - 37 UR - https://doi.org/10.1007/8904_2017_11 DO - 10.1007/8904_2017_11 ID - Zeltner2017 ER - TY - JOUR AU - Wastfelt, M. AU - Fadeel, B. AU - Henter, J. -. I. PY - 2006 DA - 2006// TI - A journey of hope: lessons learned from studies on rare diseases and orphan drugs JO - J Intern Med VL - 260 UR - https://doi.org/10.1111/j.1365-2796.2006.01666.x DO - 10.1111/j.1365-2796.2006.01666.x ID - Wastfelt2006 ER - TY - JOUR AU - Barba-Romero, M. A. AU - Rivera-Gallego, A. AU - Pintos-Morell, G. PY - 2011 DA - 2011// TI - Fabry disease in Spain: description of Spanish patients and a comparison with other European countries using data from the Fabry outcome survey (FOS) JO - Int J Clin Pract VL - 65 UR - https://doi.org/10.1111/j.1742-1241.2011.02695.x DO - 10.1111/j.1742-1241.2011.02695.x ID - Barba-Romero2011 ER - TY - JOUR AU - Rombout-Sestrienkova, E. AU - Winkens, B. AU - Essers, B. A. B. AU - Nieman, F. H. M. AU - Noord, P. A. H. AU - Janssen, M. C. H. PY - 2016 DA - 2016// TI - Erythrocytapheresis versus phlebotomy in the maintenance treatment of HFE hemochromatosis patients: results from a randomized crossover trial JO - Transfusion VL - 56 UR - https://doi.org/10.1111/trf.13328 DO - 10.1111/trf.13328 ID - Rombout-Sestrienkova2016 ER - TY - JOUR AU - Concolino, D. AU - Amico, L. AU - Cappellini, M. D. AU - Cassinerio, E. AU - Conti, M. AU - Donati, M. A. PY - 2017 DA - 2017// TI - Home infusion program with enzyme replacement therapy for Fabry disease: the experience of a large Italian collaborative group JO - Mol Genet Metab reports VL - 12 UR - https://doi.org/10.1016/j.ymgmr.2017.06.005 DO - 10.1016/j.ymgmr.2017.06.005 ID - Concolino2017 ER - TY - JOUR AU - Maselbas, W. AU - Chabik, G. AU - Czlonkowska, A. PY - 2010 DA - 2010// TI - Persistence with treatment in patients with Wilson disease JO - Neurol Neurochir Pol VL - 44 ID - Maselbas2010 ER - TY - JOUR AU - Bonnefont, J. -. P. AU - Bastin, J. AU - Behin, A. AU - Djouadi, F. PY - 2009 DA - 2009// TI - Bezafibrate for an inborn mitochondrial beta-oxidation defect JO - N Engl J Med VL - 360 UR - https://doi.org/10.1056/NEJMc0806334 DO - 10.1056/NEJMc0806334 ID - Bonnefont2009 ER - TY - JOUR AU - Wang, R. Y. AU - Lelis, A. AU - Mirocha, J. AU - Wilcox, W. R. PY - 2007 DA - 2007// TI - Heterozygous Fabry women are not just carriers, but have a significant burden of disease and impaired quality of life JO - Genet Med. VL - 9 UR - https://doi.org/10.1097/GIM.0b013e31802d8321 DO - 10.1097/GIM.0b013e31802d8321 ID - Wang2007 ER - TY - JOUR AU - Hughes, D. A. AU - Nicholls, K. AU - Shankar, S. P. AU - Sunder-Plassmann, G. AU - Koeller, D. AU - Nedd, K. PY - 2017 DA - 2017// TI - Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study JO - J Med Genet VL - 54 UR - https://doi.org/10.1136/jmedgenet-2016-104178 DO - 10.1136/jmedgenet-2016-104178 ID - Hughes2017 ER - TY - JOUR AU - Kantola, I. AU - Hietaharju, A. AU - Taurio, J. AU - Kananen, K. AU - Kantola, T. AU - Viikari, J. PY - 2012 DA - 2012// TI - P08—QUALITY OF LIFE DID NOT WORSEN FOR 7 YEARS IN ENZYME-REPLACEMENT THERAPY RECIPIENTS WITH FABRY DISEASE JO - Clin Ther VL - 34 UR - https://doi.org/10.1016/j.clinthera.2012.03.038 DO - 10.1016/j.clinthera.2012.03.038 ID - Kantola2012 ER - TY - JOUR AU - Germain, D. P. AU - Hughes, D. A. AU - Nicholls, K. AU - Bichet, D. G. AU - Giugliani, R. AU - Wilcox, W. R. PY - 2016 DA - 2016// TI - Treatment of Fabry’s disease with the pharmacologic chaperone Migalastat JO - N Engl J Med VL - 375 UR - https://doi.org/10.1056/NEJMoa1510198 DO - 10.1056/NEJMoa1510198 ID - Germain2016 ER - TY - JOUR AU - Pastores, G. M. AU - Barnett, N. L. AU - Bathan, P. AU - Kolodny, E. H. PY - 2003 DA - 2003// TI - A neurological symptom survey of patients with type I Gaucher disease JO - J Inherit Metab Dis VL - 26 UR - https://doi.org/10.1023/B:BOLI.0000005623.60471.51 DO - 10.1023/B:BOLI.0000005623.60471.51 ID - Pastores2003 ER - TY - JOUR AU - Kishnani, P. S. S. AU - DiRocco, M. AU - Kaplan, P. AU - Mehta, A. AU - Pastores, G. M. M. AU - Smith, S. E. E. PY - 2009 DA - 2009// TI - A randomized trial comparing the efficacy and safety of imiglucerase (Cerezyme) infusions every 4 weeks versus every 2 weeks in the maintenance therapy of adult patients with Gaucher disease type 1 JO - Mol Genet Metab VL - 96 UR - https://doi.org/10.1016/j.ymgme.2008.12.015 DO - 10.1016/j.ymgme.2008.12.015 ID - Kishnani2009 ER - TY - JOUR AU - Wenzel, L. B. AU - Anderson, R. AU - Tucker, D. C. AU - Palla, S. AU - Thomson, E. AU - Speechley, M. PY - 2007 DA - 2007// TI - Health-related quality of life in a racially diverse population screened for hemochromatosis: results from the hemochromatosis and Iron overload screening (HEIRS) study JO - Genet Med. VL - 9 UR - https://doi.org/10.1097/GIM.0b013e3181571f31 DO - 10.1097/GIM.0b013e3181571f31 ID - Wenzel2007 ER - TY - JOUR AU - Cotugno, G. AU - Nicolo, R. AU - Cappelletti, S. AU - Goffredo, B. M. AU - Dionisi Vici, C. AU - Di Ciommo, V. PY - 2011 DA - 2011// TI - Adherence to diet and quality of life in patients with phenylketonuria JO - Acta Paediatr VL - 100 UR - https://doi.org/10.1111/j.1651-2227.2011.02227.x DO - 10.1111/j.1651-2227.2011.02227.x ID - Cotugno2011 ER - TY - JOUR AU - Masek, B. J. AU - Sims, K. B. AU - Bove, C. M. AU - Korson, M. S. AU - Short, P. AU - Norman, D. K. PY - 1999 DA - 1999// TI - Quality of life assessment in adults with type 1 Gaucher disease JO - Qual Life Res VL - 8 UR - https://doi.org/10.1023/A:1008859420641 DO - 10.1023/A:1008859420641 ID - Masek1999 ER - TY - JOUR AU - Angelini, C. AU - Semplicini, C. AU - Tonin, P. AU - Filosto, M. AU - Pegoraro, E. AU - Sorarù, G. PY - 2009 DA - 2009// TI - Progress in enzyme replacement therapy in glycogen storage disease type II JO - Ther Adv Neurol Disord VL - 2 UR - https://doi.org/10.1177/1756285609103324 DO - 10.1177/1756285609103324 ID - Angelini2009 ER - TY - JOUR AU - Merk, T. AU - Wibmer, T. AU - Schumann, C. AU - Kruger, S. PY - 2009 DA - 2009// TI - Glycogen storage disease type II (Pompe disease)--influence of enzyme replacement therapy in adults JO - Eur J Neurol VL - 16 UR - https://doi.org/10.1111/j.1468-1331.2008.02377.x DO - 10.1111/j.1468-1331.2008.02377.x ID - Merk2009 ER - TY - JOUR AU - Svetel, M. AU - Pekmezovic, T. AU - Tomic, A. AU - Kresojevic, N. AU - Potrebic, A. AU - Jesic, R. PY - 2011 DA - 2011// TI - Quality of life in patients with treated and clinically stable Wilson’s disease JO - Mov Disord VL - 26 UR - https://doi.org/10.1002/mds.23608 DO - 10.1002/mds.23608 ID - Svetel2011 ER - TY - JOUR AU - Komal Kumar, R. N. AU - Taly, A. B. AU - Nair, K. P. S. AU - Sinha, S. AU - Prashanth, L. K. AU - Vidya, N. PY - 2008 DA - 2008// TI - Quality of life in Wilson’s disease JO - Ann Indian Acad Neurol VL - 11 UR - https://doi.org/10.4103/0972-2327.40224 DO - 10.4103/0972-2327.40224 ID - Komal Kumar2008 ER -